Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review
Authors 0
- Author list not loaded yet.
Cited by 1 stored of 15
1 result